Medigef Tablet
Introduction to Medigef Tablet
Medigef Tablet is primarily prescribed for cancer treatment. It functions by targeting epidermal growth factor receptor (EGFR) found in both normal and cancer cells, disrupting signals essential for cancer cell growth.
Gefitinib falls under the category of cancer medications and is utilized to treat specific types of cancers by inhibiting cancer cell growth. It targets the epidermal growth factor receptor (EGFR), present in both healthy and cancerous cells. By hindering specific proteins related to this receptor, Gefitinib interrupts the communication pathways crucial for cancer cell growth and survival Essentially, it halts the uncontrollable growth of cancer cells.
Follow the prescribed dose and duration as directed by your doctor. You can take this medicine with or without food but maintaining a consistent daily time is recommended for optimal results.
Common side effects may include diarrhea, dry skin, loss of appetite, nausea, rash, stomatitis (mouth inflammation), vomiting, weakness, and weight loss.
It has been associated with an increased risk of interstitial lung disease, a serious condition. Patients should be monitored for symptoms such as cough, difficulty breathing, and fever. Prompt medical attention is necessary if these symptoms occur, and treatment may need to be interrupted or discontinued.
If a dose is missed, take it when remembered. However, if the next dose is approaching, skip the missed one and continue with the regular dosing schedule. Avoid doubling doses. Consult your doctor for guidance on managing missed doses effectively.
Related Faqs
Is Geftinat a monoclonal antibody?
No this compound is not a monoclonal antibody Instead it belongs to a class of drugs known as tyrosine kinase inhibitors TKIs TKIs are a type of targeted therapy that work by blocking specific enzymes called tyrosine kinases in cancer cells These enzymes play a crucial role in the growth and division of cancer cells By inhibiting their activity TKIs can effectively slow down or prevent the growth of tumors Unlike monoclonal antibodies which act by binding to specific proteins on the surface of cancer cells TKIs work by directly interfering with the signaling pathways involved in cancer cell proliferation This targeted approach can help minimize damage to healthy cells and tissues in the body making TKIs a promising treatment option for various types of cancer However its important to note that TKIs can have side effects and their effectiveness may vary depending on the specific type and stage of cancer being treated Therefore its crucial to consult with a healthcare professional to assess the suitability of TKIs for individual patients
Is Geftib a monoclonal antibody?
No the substance in question is not a monoclonal antibody but rather a type of medication known as tyrosine kinase inhibitors These inhibitors work by targeting and blocking specific enzymes called tyrosine kinases which play a crucial role in the growth and spread of cancer cells By inhibiting these enzymes tyrosine kinase inhibitors can effectively slow down or halt the progression of certain types of cancer Unlike monoclonal antibodies which are designed to bind to specific antigens on cancer cells tyrosine kinase inhibitors focus on disrupting the signaling pathways that fuel tumor growth This approach allows for a more targeted and tailored treatment strategy as tyrosine kinases are often found in higher levels in cancer cells compared to healthy cells As a result these inhibitors can help to reduce the size of tumors prevent their spread to other parts of the body and potentially improve overall survival rates for patients It is important to note that tyrosine kinase inhibitors are typically prescribed by healthcare professionals and their usage should be closely monitored to ensure their efficacy and safety in each individual case
Is Iressa a monoclonal antibody?
No this particular drug is not a monoclonal antibody rather it falls under the category of tyrosine kinase inhibitors These inhibitors work by targeting and inhibiting the activity of tyrosine kinases a type of enzyme that plays a crucial role in various signaling pathways within cells By blocking the activity of these enzymes tyrosine kinase inhibitors can interrupt the abnormal growth and proliferation of cancer cells This targeted approach allows for more precise and specific action against cancer cells potentially leading to improved treatment outcomes and reduced side effects compared to traditional chemotherapy Tyrosine kinase inhibitors have proven to be effective in the treatment of various types of cancer including lung breast and gastrointestinal cancers among others Despite their success it is important to note that the efficacy of tyrosine kinase inhibitors can vary depending on the specific cancer type and individual patient factors Therefore it is crucial to consult with a healthcare professional to determine the most suitable treatment approach for each individual case
Is Krypton a monoclonal antibody?
No this medication is not a monoclonal antibody but rather a tyrosine kinase inhibitor Monoclonal antibodies are a type of targeted therapy that work by attaching to specific proteins on cancer cells to block their growth or kill them directly On the other hand tyrosine kinase inhibitors work by blocking the activity of specific proteins called tyrosine kinases which are involved in the signaling pathways that regulate cell growth and division These inhibitors can help prevent the growth and spread of cancer cells by interfering with the signals that promote their survival and proliferation While monoclonal antibodies and tyrosine kinase inhibitors are both used in targeted cancer therapies they work through different mechanisms and are designed to target different types of proteins in the body Therefore it is important to understand the specific mechanisms and indications of each medication before starting any treatment
Is Geftilon a monoclonal antibody?
No the substance in question does not belong to the category of monoclonal antibodies Instead it falls under the classification of tyrosine kinase inhibitors Monoclonal antibodies are a type of immunotherapy that specifically target and bind to certain proteins in the body while tyrosine kinase inhibitors are a class of drugs that work by inhibiting the activity of specific enzymes called tyrosine kinases Tyrosine kinases play a crucial role in the signaling pathways of cells including those involved in the growth and division of cancer cells By blocking the activity of these enzymes tyrosine kinase inhibitors can help slow down or stop the growth and spread of cancer While both monoclonal antibodies and tyrosine kinase inhibitors are used in the treatment of various diseases it is important to understand the specific mechanism of action and therapeutic benefits associated with each type of medication
Is Gefitero a monoclonal antibody?
No it is not a monoclonal antibody Instead it belongs to the class of tyrosine kinase inhibitors These inhibitors work by blocking the activity of specific enzymes called tyrosine kinases which are essential for the growth and division of cancer cells By inhibiting these enzymes tyrosine kinase inhibitors can help slow down or stop the progression of certain types of cancer Unlike monoclonal antibodies which target specific proteins on the surface of cancer cells tyrosine kinase inhibitors act on the intracellular signaling pathways that promote cancer cell growth This mechanism of action makes tyrosine kinase inhibitors suitable for targeting cancers that are driven by specific genetic mutations or abnormal signaling pathways However it is important to note that tyrosine kinase inhibitors are not effective for all types of cancer and may have side effects It is essential to consult with a healthcare professional to determine if this class of drugs is appropriate for a specific cancer diagnosis and treatment plan
Disclaimer : This information is not a substitute for medical advice. Consult your healthcare provider before making any changes to your treatment . Do not ignore or delay professional medical advice based on anything you have seen or read on Medwiki.
Medigef Tablet
Prescription Required
Packaging :
bottle of 10 tablets
Manufacturer :
Medion Biotech Pvt LtdComposition :
Gefitinib (250mg)MRP :
Related Posts
1:15
3 Practical Tips to Improve Quality of Life for Dementia Patients!
1:15
Vidya Balan's Weight Loss: Proven Tips for Your Dream Body!
1:15
3 lifestyle changes that can help reduce the risk of Dementia!
1:15
The Impact of long term untreated Sleep Apnea on Your Health!
1:15
The dangers of too much caffeine consumption!
.svg)
